Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: A meta-analysis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 30

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

781

HTML

9094

Figures (1-3)

253

Tables (1-8)

247

Sum=10375

Aug 14, 2012 (publication date) through Nov 3, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Aug 14, 2012; 18(30): 4004-4011
Published online Aug 14, 2012. doi: 10.3748/wjg.v18.i30.4004

Full Size Figure Download Figure

Figure 3 Percentage of faecal pyruvate kinase isoenzyme type M2-positive volunteers by age group (from Tonus et al[49]).

Citation: Tonus C, Sellinger M, Koss K, Neupert G. Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: A meta-analysis. World J Gastroenterol 2012; 18(30): 4004-4011
URL: https://www.wjgnet.com/1007-9327/full/v18/i30/4004.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i30.4004